Skip to content

To compare the effect of dexamethasone and dexmedetomidine to ropivacaine in ultrasound guided transverse abdominis block for postoperative pain relief in caesarean section

Comparison of analgesic efficacy of dexamethasone versus dexmedetomidine as an adjuvant to ropivacaine in ultrasound guided transverse abdominis block for postoperative pain relief in caesarean section

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/026995
Enrollment
100
Registered
2020-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: transverse abdominis block: comparison of analgesic efficacy of dexamethasone versus dexmedetomidine as an adjuvant to ropivacaine in ultrasound guided transverse abdominis block for po

Sponsors

Dmch
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA-1,2,3

Exclusion criteria

Exclusion criteria: Any contraindication to spinal anesthesia; history of recent opioid exposure; hypersensitivity to any drugs used in study; significant cardiovascular, renal or hepatic diseases and known fetal abnormalities

Design outcomes

Primary

MeasureTime frame
Time to initial postoperative pain and first rescue analgesic. Adverse effects if anyTimepoint: outcome will be assessed immediately after shifting the patient to recovery, every hrly until the patient experience pain with VAS more than 3

Secondary

MeasureTime frame
Time to initial rescue analgesic. Adverse effects if anyTimepoint: outcome will be assessed immediately after shifting the patient to recovery, every hrly until the patient experience pain with VAS more than 3, we will give i.m diclofenac 75mg

Countries

India

Contacts

Public ContactKamakshi garg

Dayanand medical college and hospital ,ludhiana

drkamakshigarg@gmail.com9814444121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026